Vafa Guliyeva

Vafa Guliyeva

Auto-generated profile, based on publicly available information

Vafa Guliyeva

Department of Pediatric Rheumatology, Istanbul University Istanbul Faculty of Medicine , Istanbul

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
FHFatih Haslak
Fatih Haslak
KBKenan Barut
Kenan Barut
CDCANSU DURAK
CANSU DURAK
AAAyten Aliyeva
Ayten Aliyeva
MYMehmet YILDIZ
Mehmet YILDIZ
OKOzgur Kasapcopur
Ozgur Kasapcopur

1 March 2023 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
FHFatih Haslak
Fatih Haslak
VGVafa Guliyeva
Vafa Guliyeva
BHBüşra Hotaman
Büşra Hotaman
ÇDÇisem Duman
Çisem Duman
MYMehmet YILDIZ
Mehmet YILDIZ
OKOzgur Kasapcopur
Ozgur Kasapcopur
Objective: Juvenile idiopathic arthritis is a heterogeneous group of disorders and is the most common rheumatic condition in childhood. There are scarce data regarding all comorbidities in juvenile idiopathic arthritis patients. Materials and Methods: We aimed to identify the non-rheumatic comorbidities in our juvenile idiopathic arthritis patients. Data were obtained cross-sectionally from the medical records and the face-to-face interviews for 6 consecutive months. Those with more than 1 rheumatic disease were excluded, and conditions that were highly related to the disease, such as uveitis, were not taken into account. Results: The study included 459 patients with female dominance (62.1%, n = 285). The median age of the patients was 12.87 (1.53-20.95) years. One hundred fifty patients (32.7%) had at least 1 comorbidity (5 patients had 3 comorbidities, and 24 patients had 2 comorbidities). The most common 3 non-rheumatic accompanying medical conditions in our patients were allergic rhinitis (n = 37, 8.1%), attention-deficit hyperactivity disorder (n = 35, 7.6%), and atopic dermatitis (n = 28, 6.1%). None of our patients with systemic JIA had any autoimmune disease. All the patients with primary immune deficiencies had anti-nuclear antibody positivity. Conclusion: Almost one-third of our patients had at least one comorbidity. This finding might be very helpful to us in planning our multi-disciplinary approach to our patients. Cite this article as: Haşlak F, Guliyeva V, Hotaman B, et al. Non-rheumatic chronic comorbidities in children with juvenile idiopathic arthritis. Turk Arch Pediatr. 2023;58(2):212-219.

19 January 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
FHFatih Haslak
Fatih Haslak
DÖDoğukan Özbey
Doğukan Özbey
MYMehmet YILDIZ
Mehmet YILDIZ
AAAmra Adrovic Adrovic
Amra Adrovic Adrovic
SSSezgin Sahin
Sezgin Sahin
KBKenan Barut
Kenan Barut

21 March 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HSHafize Emine Sönmez
Hafize Emine Sönmez
SCSengul Caglayan
Sengul Caglayan
GYgulcin otar yener
gulcin otar yener
EBEviç Zeynep Başat
Eviç Zeynep Başat
KUKadir Ulu
Kadir Ulu
BSBetul Sozeri
Betul Sozeri
Background: The aim of this study was to evaluate the outcomes of patients with the multisystem inflammatory syndrome in children (MIS-C) according to phenotypes of disease and define the prognostic factors for the severe course. Methods: This cross-sectional study included 293 patients with MIS-C from seven pediatric rheumatology centers. A two-step cluster analysis was performed to define the spectrum of disease and their outcomes were compared between each group. Results: Four subgroups were identified as follows: cluster I, predominantly Kawasaki-like features (n = 100); cluster II, predominantly MAS-like features (n = 34); cluster III, predominantly LV dysfunction (n = 47); cluster IV, other presentations (n = 112). The duration of fever was longer in cluster II and the length of hospitalization was longer in both clusters II and III. Laboratory findings revealed lower lymphocyte and platelet counts and higher acute phase reactants (APRs) in cluster II, while patients in cluster IV showed less inflammation with lower APRs. The resolution of abnormal laboratory findings was longer in clusters II and III, while it was shortest in cluster IV. Seven patients died. Among them, four belonged to cluster II, while three were labeled as cluster III. Patients with severe course had higher levels of neutrophil–lymphocyte ratio, mean platelet volume, procalcitonin, ferritin, interleukin-6, fibrinogen, D-Dimer, BNP, and troponin-I, and lower levels of lymphocyte and platelet counts. Conclusion: As shown, MIS-C is not a single disease presenting with various clinical features and outcomes. Understanding the disease spectrum will provide individualized management.

21 May 2025 in Rheumatology
Verified
Journal Article
Open access
VGVafa Guliyeva
Vafa Guliyeva
FDFatma Gül Demirkan
Fatma Gül Demirkan
EBErdem Bektaş
Erdem Bektaş
RDRabia Deniz
Rabia Deniz
ZEZeliha Emrence
Zeliha Emrence
NANuray Aktay Ayaz
Nuray Aktay Ayaz
Objectives: The role of neutrophil extracellular traps (NETs) in IgA vasculitis (IgAV) pathogenesis is emerging, with NETosis-associated markers potentially linked to disease activity. This study aimed to explore the relationship between NETosis biomarkers and IgAV disease phases. Methods: A longitudinal study involving 33 paediatric IgAV patients and 26 healthy controls was conducted. Blood and urine samples were collected from healthy controls and patients during active and inactive disease phases. NETosis markers, including cell-free DNA (cf-DNA), neutrophil elastase, MPO and citrullinated histone H3 (cit-H3) were measured using ELISA kits. Statistical analyses were conducted to compare differences for NETosis markers between groups and to evaluate correlations among variables using appropriate statistical tests. Results: There was no significant difference in gender and age between the patient and control groups. The serum cf-DNA level was significantly higher in the active patient group compared with the control and inactive patient groups (P = 0.04; P = 0.04, respectively). In urine, MPO levels were significantly lower in the active phase of patients than controls (P = 0.009), while cit-H3 levels were higher in both active and inactive phases compared with controls (P = 0.01 and P = 0.03, respectively). A cf-DNA threshold of 935 ng/ml was identified, which achieved a sensitivity of 93% (correctly identifying 93% of active patients) and a specificity of 72% (correctly identifying 72% of healthy controls). Conclusion: Elevated serum cf-DNA and urine cit-H3 suggest a potential role for NETosis in IgAV activity, highlighting these markers as potential indicators for disease monitoring. Further studies are warranted to establish standardized protocols for NETosis marker assessment in IgAV.

13 October 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
FCFigen Cakmak
Figen Cakmak
ÖAÖzlem Akgün
Özlem Akgün
FDFatma Gül Demirkan
Fatma Gül Demirkan
ATAyşe Tanatar
Ayşe Tanatar
GKGülşah Kavrul Kayaalp
Gülşah Kavrul Kayaalp
NANuray Aktay Ayaz
Nuray Aktay Ayaz